Assurant, Inc. AIZ
Set alert
298.32 USD +1.09 +0.37%
As of Nov 3, 11:55 AM ET
293.53 Day range 299.40
211.86 52-week range 301.57
- YTD
- +23.86%
- 1 year
- +40.64%
- Open
- 296.39
- Prev close
- 297.23
- Mkt cap
- 14.72B
- Vol
- 77.33K
- Avg vol
- 368.25K
- EPS
- 20.89
- P/E
- 14.29
- Div yield
- 1.20%
More statistics
- Low
- 293.53
- High
- 299.40
- Forward P/E
- 12.68
- Beta
- 0.51
- Short ratio
- 3.48
- Inst. own
- 100.37%
- Dividend
- 3.52
- Ex-div date
- Aug 30, 2026
- Earnings
- Nov 3, 2026
- 50-d avg
- 278.75
- 200-d avg
- 254.52
- 1y target
- 326.67
MAX chart
Events in this range
- Feb 2, 2024Dividend: 0.72
- Feb 5, 2024Dividend: 0.72
- Sep 3, 2024Dividend: 0.72
- Feb 3, 2025Dividend: 0.8
- Aug 5, 2025Earnings: 5.1; estimate 4.43; surprise 15.12%
- Sep 2, 2025Dividend: 0.8
- Nov 4, 2025Earnings: 5.73; estimate 4.39; surprise 30.52%
- Dec 1, 2025Dividend: 0.88
- May 5, 2026Earnings: 5.95; estimate 5.29; surprise 12.48%
- Aug 4, 2026Earnings: 6.6; estimate 5.17; surprise 27.66%
- Aug 6, 2026Rating: Piper Sandler · Overweight → Overweight
- Aug 7, 2026Rating: Keefe, Bruyette & Woods · Outperform → Outperform
- Oct 6, 2026Rating: Morgan Stanley · Overweight → Overweight
- Nov 3, 2026Earnings: —; estimate 4.75; surprise —%
Signals (100)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Nov 3, 2026 | 2 hours ago |
| RSI: Overbought | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Mar 1, 2026 | 8 months ago |
| MACD: Buy Signal | Nov 1, 2025 | 1 year ago |
| SMA: Bullish | Aug 1, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 1, 2025 | 1 year ago |
| SMA: Bearish | Apr 1, 2025 | 1 year ago |
| RSI: Overbought | Nov 1, 2024 | 2 years ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
| SMA: Bearish | Jun 1, 2024 | 2 years ago |
| RSI: Overbought | Mar 1, 2024 | 2 years ago |
| SMA: Bullish | Nov 1, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 1, 2023 | 3 years ago |
| SMA: Bullish | Jul 1, 2023 | 3 years ago |
| SMA: Bearish | Sep 1, 2022 | 4 years ago |
| SMA: Bearish | Aug 1, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 1, 2022 | 4 years ago |
| SMA: Bullish | Feb 1, 2022 | 4 years ago |
| MACD: Buy Signal | Feb 1, 2022 | 4 years ago |
Newest 20 of 100.
Analyst view
Price target (mean) 326.67 +9.5% upside
Now 298.32
- Target (low)
- 300.00
- Target (mean)
- 326.67
- Target (high)
- 355.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy3
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 4.71 | 4.41 – 5.26 | 5.73 | -17.8% | 3.45B | +6.8% | 7 |
| Next quarter | 5.40 | 4.96 – 5.74 | 5.61 | -3.8% | 3.56B | +6.1% | 7 |
| Current year | 22.47 | 21.75 – 23.28 | 19.77 | +13.7% | 13.86B | +8.1% | 7 |
| Next year | 23.45 | 22.97 – 24.00 | 22.47 | +4.4% | 14.62B | +5.5% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 6, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 28, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Aug 19, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 13, 2026 | UBS | Maintained | Buy | Buy |
| Aug 7, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 6, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 8, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Jul 6, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 17, 2026 | Truist Securities | Maintained | Buy | Buy |
| May 26, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| May 14, 2026 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| May 13, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| May 11, 2026 | UBS | Maintained | Buy | Buy |
| May 11, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| May 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Apr 6, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Feb 12, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Feb 12, 2026 | Truist Securities | Maintained | Buy | Buy |
| Dec 19, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Nov 20, 2025 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Nov 17, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 10, 2025 | UBS | Maintained | Buy | Buy |
| Oct 10, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 8, 2025 | UBS | Maintained | Buy | Buy |
| Oct 7, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 18, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 12, 2025 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Aug 12, 2025 | BMO Capital | Initiated | — | Outperform |
| Jul 14, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
